RALYL and colorectal carcinoma: As far as P38 pathway activation in cancer is concerned [17, 18, 19], in our study, RALYL, HNRNPC, and p38 were investigated, and the results indicated that HNRNPC and p38 are associated with the role of RALYL in CRC.